Close menu




December 23rd, 2024 | 08:25 CET

SHARE PRICE RALLY 2025 or cash in? Siemens Energy, thyssenkrupp nucera, Myriad Uranium

  • Mining
  • Uranium
  • renewableenergies
  • Energy
Photo credits: thyssenkrupp nucera

Will the Siemens Energy share continue its price rally in 2025? This year, the Siemens Energy share was the top performer in the DAX. The problems in the wind sector were outshone by the boom in the gas and grid business. Now, the major shareholder wants to cash in! What do analysts say? The chances are good that the rally will continue for Myriad Uranium. The newsflow is positive, analysts see a lot of potential, and a capital increase was easily placed. Analysts are divided on the upside potential for thyssenkrupp nucera. Is a 100% rally possible for the German hydrogen hopeful?

time to read: 4 minutes | Author: Fabian Lorenz
ISIN: SIEMENS ENERGY AG NA O.N. | DE000ENER6Y0 , THYSSENKRUPP AG O.N. | DE0007500001 , MYRIAD URANIUM CORP | CA62857Y1097 , THYSSENKRUPP NUCERA AG & CO KGAA | DE000NCA0001

Table of contents:


    John Jeffrey, CEO, Saturn Oil & Gas Inc.
    "[...] When we acquire something, we want to make sure that the acquisition fits with our strategy and has the potential to be successful for our shareholders. [...]" John Jeffrey, CEO, Saturn Oil & Gas Inc.

    Full interview

     

    Myriad Uranium: Will the price rally continue in 2025?

    Uranium was one of the positive surprises of the year. 2024 showed that there is no way around nuclear energy for the foreseeable future. The energy demand is driven, among other things, by artificial intelligence data centres and the simultaneous pressure to achieve CO2 neutrality. In this environment, the Myriad Uranium share has more than doubled in the current year. Investors seem to be betting on further price increases, as a few days ago, an oversubscribed capital increase was implemented. Myriad holds a 75% majority in the Copper Mountain uranium project in the US state of Wyoming and could increase this to 100%. In addition, the Company has a 50% interest in the Millen Mountain project in Canada. The analysts at Singular Research recommended the Myriad share as a "Buy" before the capital increase, with a target price of USD 1.35. The security is currently trading at USD 0.27. In October, the share also traded above USD 0.40. After the successful capital increase, this mark can be targeted again.

    The fresh funds will be used to conduct further geophysical surveys and start another drilling program. This should continue the positive news flow in the coming year. The drilling program in the current year exceeded expectations. The historical resources were verified, and the potential for deeper uranium mineralization was demonstrated. The Company announced in November that the results of over 1,000 ppm, with a peak content of 8,060 ppm in 34 drill holes, were excellent. The grade will likely be revised upwards by around 13% in the detailed analysis. Read the full announcement here).

    Siemens Energy: Cashing in?

    In 2024, the Siemens Energy share has performed even better than Myriad Uranium. But are the prospects for 2025 similarly attractive? At least for the coming months, a consolidation would not be surprising. On the one hand, the turnaround seems to be more than sufficiently priced in. After all, the Company is now valued at more than EUR 40 billion.

    In addition, the major shareholder wants to cash in. In an interview with Bloomberg, Siemens CFO Ralf Thomas spoke of wanting to reduce its stake in Siemens Energy from the current 17% to 11%. Selling the block of shares at the current price level would net Siemens over EUR 2 billion. The transaction is expected to be completed by September 2025. The cash inflow will be used to help pay for part of the purchase price of Altair. Siemens announced in October that it wanted to take over the US software group for USD 10 billion. A few days ago, the Federal Cartel Office gave the green light for the acquisition.

    The planned share sale could initially weigh on the price of Siemens Energy shares. Analysts also see only limited upside potential. The vast majority of analysts recommend buying the DAX company's securities, but the upside targets are modest. For example, Deutsche Bank recently confirmed its "Buy" recommendation and raised its upside target slightly. However, given the current price of just over EUR 50, the analysts' fair value of EUR 58 is modest. JPMorgan even rates the Siemens Energy share only as "Neutral". The price target is EUR 44, more than 10% below the current listing.

    thyssenkrupp nucera: A 100% candidate?

    While Myriad Uranium and Siemens Energy have performed positively in the current year, 2024 has been a year to forget for shareholders of thyssenkrupp nucera. The stock of the German hydrogen hopeful has lost more than 40% of its value over the course of the year. Although the Company seems to be in a better position than Plug Power and Nel ASA, this is no reason to buy for the time being. On the other hand, hydrogen is considered important in the energy mix of the future.

    Despite the challenging environment for hydrogen, the Company is optimistic about the future. Dr Werner Ponikwar, CEO of thyssenkrupp nucera, said on the occasion of the 2023/24 annual figures: "The long-term growth prospects of thyssenkrupp nucera remain intact. We have a strong financial base and are excellently positioned for growth in the green hydrogen market with our technology, products and employees. With our high investments in line with market developments in the future of thyssenkrupp nucera, we are consistently driving the scaling of our business and strengthening our competitiveness and profitability in the long term and sustainably. We can easily cope with the current phase of temporarily somewhat slower growth with our stable cash flow from the chlor-alkali business and our asset-light business model." Although thyssenkrupp nucera also has an EBIT loss, it is in a much more solid position than Nel or Plug Power. In addition, the Company showed last year that it can also make a profit. The Norwegians and Americans still have to prove this to investors.

    Analysts are divided. Last Friday was a case in point. Berenberg, for example, again advised holding thyssenkrupp nucera shares, noting that the Company's outlook to 2025 is solid. However, more major orders are needed to be able to recommend the share as a buy. The analysts see the fair value of the share at EUR 12, while it is currently trading just above EUR 10. By contrast, Bernstein Research is bullish on the thyssenkrupp nucera share. In the green hydrogen sector, they believe the share is the right choice. The analysts' target price is 20% higher, translating to a good 100% above the current level. As a result, they recommend the thyssenkrupp nucera share as "Outperform".


    There is much to suggest that Myriad Uranium's share price will rise in 2025. Energy demand continues to rise worldwide, and outside of Germany, there is agreement that, in addition to renewable energies, nuclear energy is also needed to meet this demand. With the project in the US, it is active precisely where Microsoft, Amazon and Co. are investing in nuclear energy. Siemens Energy is still well positioned, but after the rally, the share price performance should normalize in 2025. thyssenkrupp nucera may be best positioned in the hydrogen sector, but an investment is not currently compelling given the challenging industry environment.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Fabian Lorenz on April 23rd, 2025 | 07:20 CEST

    40% SHARE PRICE EXPLOSION! Commodity war drives Standard Lithium and BMW partner European Lithium! News from Evotec!

    • Mining
    • Lithium
    • Batteries
    • Defense
    • Biotechnology

    Price explosion at Standard Lithium! The share price rose by more than 40% yesterday. The joint venture with Norwegian energy company Equinor has been classified as a "critical mineral project" by the US government. This indicates that the raw materials war with China goes far beyond rare earths. European Lithium has lithium and rare earths to offer. The stock is a real bargain, as illustrated by the new details on the rare earth project in Greenland. Talks are already underway with defense companies from the US and Europe, and analysts see multiplication potential. Evotec shareholders had likely hoped for a somewhat bigger price explosion following the presentation of the new corporate strategy. However, the biotech company is bidding farewell to its strong growth trajectory.

    Read

    Commented by Nico Popp on April 23rd, 2025 | 07:00 CEST

    The end of the dollar? Deutsche Bank, Newmont, and Desert Gold

    • Mining
    • Gold
    • Investments

    The independence of the central bank is a valuable asset that is highly valued by investors. Once again, US President Donald Trump has shaken the independence of the Fed and raised the possibility of dismissing US Federal Reserve Chairman Jerome Powell. The reason: While the ECB cut interest rates on Maundy Thursday, Powell wants to wait and see how the tariffs affect the dollar zone before he adjusts interest rates. Powell's dismissal could have fatal consequences for the capital markets.

    Read

    Commented by Stefan Feulner on April 22nd, 2025 | 07:50 CEST

    Almonty Industries – Escalation level raised

    • Mining
    • Tungsten
    • Investments

    The trade war between the US and China reached a new level last week. On "Liberation Day", US President Trump raised punitive tariffs to an incredible 125%, prompting China to respond with export controls on rare earth metals that are essential for the manufacture of electric motors, batteries, and magnets, as well as for the defense industry. Similar restrictions on gallium, germanium, and tungsten have also been in place since the end of last year. At least in the case of tungsten, which is needed for use in armor-piercing ammunition, for example, there are signs of easing tensions with the start of production at the Sangdong mine in South Korea. The operating company's share price, Almonty Industries, has partially met expectations in recent months, but analysts believe it still holds significant upside potential.

    Read